People
Associate
Bren Moreno is an associate on the FDA & Life Sciences team in King & Spalding's Washington, D.C., office. Bren counsels pharmaceutical, biotechnology, and medical device manufacturers on a variety of regulatory and compliance issues.
After studying Biology and Bioethics at the Ohio State University, Bren attended Saint Louis University School of Law, where she served as president of the Health Law Association and Notes & Comments Managing Editor of the Journal of Health Law & Policy.
J.D., Saint Louis University School of Law, summa cum laude
B.S. Biology, The Ohio State University, summa cum laude
December 19, 2023
The Administration Takes Aim At Drug Prices Again – This Time Through A Controversial Framework for Exercising March-In Rights
August 24, 2023
FDA Issues Draft Guidance for Obtaining Postmarket Data on Underrepresented Populations in Drug Clinical Trials
March 27, 2023
With Risk Comes Responsibility: EU Proposes High-Risk AI Regulation Affecting Device Manufacturers
December 19, 2023
The Administration Takes Aim At Drug Prices Again – This Time Through A Controversial Framework for Exercising March-In Rights
August 24, 2023
FDA Issues Draft Guidance for Obtaining Postmarket Data on Underrepresented Populations in Drug Clinical Trials
March 27, 2023
With Risk Comes Responsibility: EU Proposes High-Risk AI Regulation Affecting Device Manufacturers
J.D., Saint Louis University School of Law, summa cum laude
B.S. Biology, The Ohio State University, summa cum laude